-
Successful treatment of respiratory failure in Hirayama disease
Sol, N., Hartman, J., ten Kate, M., van Kempen, Z., van der Kooi, A., Vandertop, P., Tuinman, P-R. & van Oosten, B., 1 Feb 2024, In: American Journal of Emergency Medicine. 76, p. 272.e3-272.e5Research output: Contribution to journal › Article › Academic › peer-review
-
Exploring the effects of extended interval dosing of natalizumab and drug concentrations on brain atrophy in multiple sclerosis
Toorop, A. A., Noteboom, S., Steenwijk, M. D., Gravendeel, J. W., Jasperse, B., Barkhof, F., Strijbis, E. M. M., Rispens, T., Schoonheim, M. M., van Kempen, Z. L. E. & Killestein, J., Feb 2024, In: MULTIPLE SCLEROSIS JOURNAL. 30, 2, p. 266-271 6 p.Research output: Contribution to journal › Article › Academic › peer-review
-
Cross-Reactivity of Antibodies to Rituximab with Other Therapeutic Anti-CD20 Antibodies
Rispens, T., Kuijpers, T. W., Killestein, J., van Kempen, Z. L. E. & Bloem, K., 27 Dec 2023, (E-pub ahead of print) In: Journal of immunology (Baltimore, Md..Research output: Contribution to journal › Article › Academic › peer-review
- All publications